These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18318892)

  • 1. A global view of drug-therapy interactions.
    Nacher JC; Schwartz JM
    BMC Pharmacol; 2008 Mar; 8():5. PubMed ID: 18318892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systems biology approach to drug discovery.
    Zhu J; Zhang B; Schadt EE
    Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences.
    Tucker GT; Houston JB; Huang SM
    Eur J Pharm Sci; 2001 Jul; 13(4):417-28. PubMed ID: 11480400
    [No Abstract]   [Full Text] [Related]  

  • 9. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology approaches and tools for analysis of interactomes and multi-target drugs.
    Schrattenholz A; Groebe K; Soskic V
    Methods Mol Biol; 2010; 662():29-58. PubMed ID: 20824465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
    Barneh F; Jafari M; Mirzaie M
    Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Novel Drug-like Molecules Using Informatics Rich Secondary Metabolites Analysis of Indian Medicinal and Aromatic Plants.
    Karade D; Vijayasarathi D; Kadoo N; Vyas R; Ingle PK; Karthikeyan M
    Comb Chem High Throughput Screen; 2020; 23(10):1113-1131. PubMed ID: 32504496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems psychopharmacology: A network approach to developing novel therapies.
    Gebicke-Haerter PJ
    World J Psychiatry; 2016 Mar; 6(1):66-83. PubMed ID: 27014599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A landscape for drug-target interactions based on network analysis.
    Galan-Vasquez E; Perez-Rueda E
    PLoS One; 2021; 16(3):e0247018. PubMed ID: 33730052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome and network visualization facilitates the analyses of the effects of drugs and mutations on protein-protein and drug-protein networks.
    Céol A; Verhoef LG; Wade M; Muller H
    BMC Bioinformatics; 2016 Mar; 17 Suppl 4(Suppl 4):54. PubMed ID: 26961139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Approaches to the New Drugs Approved During 2017.
    Flick AC; Leverett CA; Ding HX; McInturff E; Fink SJ; Helal CJ; O'Donnell CJ
    J Med Chem; 2019 Aug; 62(16):7340-7382. PubMed ID: 30939001
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.